Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Beluga NV | BELU | Jun 13, 2024 | 1.08 | 0.00 |
Belysse Group N.V. | BELYS | Jun 13, 2024 | 0.88 | 0.00 |
Biocartis Group NV | BCART | Jun 13, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | Jun 13, 2024 | 0.02 | +6.49 |
Biotalys | BTLS | Jun 13, 2024 | 2.81 | -3.10 |
Boeing | BOEI | Jun 13, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Jun 13, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Jun 13, 2024 | 3.12 | -2.04 |
Brederode S.A. | BREB | Jun 13, 2024 | 114.40 | -1.89 |
Campine nv | CAMB | Jun 13, 2024 | 75.00 | 0.00 |
Candela Invest | CAND | Jun 13, 2024 | 2.80 | 0.00 |
Care Property Invest NV/SA | CPINV | Jun 13, 2024 | 14.02 | -1.54 |
Celyad Oncology SA | CYAD | Jun 13, 2024 | 0.31 | +3.16 |
Cenergy Holdings | CENER | Jun 13, 2024 | 9.10 | -1.52 |
Chevron | CHTEX | Jun 13, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Jun 13, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Jun 13, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Jun 13, 2024 | 57.85 | -1.45 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Jun 13, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Jun 13, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Jun 13, 2024 | 44.56 | -0.98 |
Compagnie du Bois Sauvage S.A. | COMB | Jun 13, 2024 | 270.00 | -1.46 |
Compagnie d`Entreprises CFE SA | CFEB | Jun 13, 2024 | 7.72 | -1.03 |
Connect Group | CONN | Jun 13, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | Jun 13, 2024 | 0.01 | -1.64 |
Cumulex NV | CLEX | Jun 13, 2024 | 1.35 | 0.00 |
CURETIS | CURE | Jun 13, 2024 | 0.29 | 0.00 |
Deceuninck NV. | DECB | Jun 13, 2024 | 2.60 | +0.39 |
Deme Group N.V. | DEME | Jun 13, 2024 | 159.20 | +0.25 |
Deutsche Telekom AG | DTEL | Jun 13, 2024 | 20.00 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.